Last update:

Allergy and immunology news

How lung tumors use the brain to avoid immune attacks

University of Pennsylvania Perelman School of Medicine and Yale University School of Medicine, along with other collaborators, report that lung adenocarcinoma can engage nerve pathways that link the lung to the brainstem ...

What drives food allergies? New study pinpoints early-life factors that raise risk

A new study from McMaster University involving 2.8 million children around the world has revealed the most important early-life factors that influence whether a child becomes allergic to food.

Immune 'hijacking' by tumors can predict cancer evolution

Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and the Ludwig Institute for Cancer Research have discovered that neutrophils, a type of immune cell, ...

Why antibiotic allergy labels deserve a second look

In modern medicine, antibiotics are among the most powerful tools for preventing and treating life-threatening bacterial infections. Their effectiveness, however, often depends on using the right drug at the right time. Recognizing ...

A genetic blueprint for avoiding killer T cell exhaustion

A multi-institutional study led by researchers at UNC Lineberger Comprehensive Cancer Center, the Salk Institute for Biological Studies, and UC San Diego has uncovered new genetic rules that determine how powerful immune ...

A more reliable platform to test antibody medicines

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published in Science Immunology, ...

How does long COVID develop? New piece of the puzzle found

How long COVID develops is still largely unknown. New molecular connections are revealed in a recent study led by the Center for Individualized Infection Medicine (CiiM), which is a joint institution of the Helmholtz Center ...

Certain antibiotics may may boost immune system

Research led by Lancaster University has discovered that a class of antibiotics—fluoroquinolones—can directly alter the potential bacterial killing ability of one of our immune cells called the macrophage.